| 002F36 (2003) |
Bhagu R. Bhavnani [Canada] | Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's |
| 000164 (2016) |
Am Alaqeel [Canada, Arabie saoudite] ; H. Abou Al-Shaar [Arabie saoudite] ; Rk Shariff [Arabie saoudite] ; A. Albakr [Arabie saoudite] | The role of RNA metabolism in neurological diseases |
| 000902 (2014) |
Cristian A. Droppelmann [Canada] ; Danae Campos-Melo [Canada] ; Kathryn Volkening [Canada] ; Michael J. Strong [Canada] | The emerging role of guanine nucleotide exchange factors in ALS and other neurodegenerative diseases |
| 001100 (2012) |
Lise N. Munsie ; Ray Truant | The role of the cofilin-actin rod stress response in neurodegenerative diseases uncovers potential new drug targets |
| 001600 (2011) |
J. Robert Chang [États-Unis] ; Mohammad Ghafouri [Canada] ; Ruma Mukerjee [États-Unis] ; Asen Bagashev [États-Unis] ; Tinatin Chabrashvili [États-Unis] ; Bassel E. Sawaya [États-Unis] | Role of p53 in Neurodegenerative Diseases |
| 001619 (2011) |
Katie Facecchia [Canada] ; Lee-Anne Fochesato [Canada] ; Sidhartha D. Ray [États-Unis] ; Sidney J. Stohs [États-Unis] ; Siyaram Pandey [Canada] | Oxidative Toxicity in Neurodegenerative Diseases: Role of Mitochondrial Dysfunction and Therapeutic Strategies |
| 002694 (2007) |
Manon Lebel [Canada] ; Pierre Robinson [Canada] ; Michel Cyr [Canada] | Canadian association of neurosciences review : The role of dopamine receptor function in neurodegenerative diseases |
| 002930 (2006) |
Charles Ramassamy [Canada] | Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases : A review of their intracellular targets |
| 002F62 (2002) |
A V Rao [Canada] ; B. Balachandran | Role of oxidative stress and antioxidants in neurodegenerative diseases. |
| 003846 (1998) |
P. Desjardins [Canada] ; S. Ledoux | The role of apoptosis in neurodegenerative diseases. |
| 004659 (1992) |
E. G. Mcgeer [Canada] ; E. A. Singh | Angiotensin-converting enzyme in cortisal tissue in Alzheimer's and some other neurological diseases |
| 000010 (2017) |
Mahshad Kolahdouzan [Canada] ; Mazen J. Hamadeh [Canada] | The neuroprotective effects of caffeine in neurodegenerative diseases. |
| 000058 (2017) |
Jordan Alexander Mckenzie ; Lindsay J. Spielman ; Caitlin B. Pointer ; Jessica R. Lowry ; Ekta Bajwa ; Carolyn W. Lee ; Andis Klegeris | Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer's and Parkinson`s Diseases. |
| 000187 (2016) |
Gerald W. Zamponi [Canada] | Targeting voltage-gated calcium channels in neurological and psychiatric diseases. |
| 000203 (2016) |
Moonhee Lee ; Edith G. Mcgeer ; Patrick L. Mcgeer | Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases |
| 000341 (2016) |
Rita Guerreiro [Royaume-Uni] ; Valentina Escott-Price [Royaume-Uni] ; Lee Darwent [Royaume-Uni] ; Laura Parkkinen [Royaume-Uni] ; Olaf Ansorge [Royaume-Uni] ; Dena G. Hernandez [États-Unis, Allemagne] ; Michael A. Nalls [États-Unis] ; Lorraine Clark [États-Unis] ; Lawrence Honig [États-Unis] ; Karen Marder [États-Unis] ; Wiesje Van Der Flier [Pays-Bas] ; Henne Holstege [Pays-Bas] ; Eva Louwersheimer [Pays-Bas] ; Afina Lemstra [Pays-Bas] ; Philip Scheltens [Pays-Bas] ; Ekaterina Rogaeva [Canada] ; Peter St George-Hyslop [Canada, Royaume-Uni] ; Elisabet Londos [Suède] ; Henrik Zetterberg [Suède, Royaume-Uni] ; Sara Ortega-Cubero [Espagne] ; Pau Pastor [Espagne] ; Tanis J. Ferman [États-Unis] ; Neill R. Graff-Radford [États-Unis] ; Owen A. Ross [États-Unis] ; Imelda Barber [Royaume-Uni] ; Anne Braae [Royaume-Uni] ; Kristelle Brown [Royaume-Uni] ; Kevin Morgan [Royaume-Uni] ; Walter Maetzler [Allemagne] ; Daniela Berg [Allemagne] ; Claire Troakes [Royaume-Uni] ; Safa Al-Sarraj [Royaume-Uni] ; Tammaryn Lashley [Royaume-Uni] ; Yaroslau Compta [Royaume-Uni, Espagne] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees [Royaume-Uni] ; Nigel J. Cairns [États-Unis] ; Glenda M. Halliday [Australie] ; David Mann [Royaume-Uni] ; Stuart Pickering-Brown [Royaume-Uni] ; John Powell [Royaume-Uni] ; Katie Lunnon [Royaume-Uni] ; Michelle K. Lupton [Royaume-Uni] ; Dennis Dickson [États-Unis] ; John Hardy [Royaume-Uni] ; Andrew Singleton [États-Unis] ; Jose Bras [Royaume-Uni] | Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases |
| 000485 (2015) |
Zhen Ni ; Robert Chen | Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases |
| 000493 (2015) |
Marcus W. Koch [Canada] ; Lawrence Korngut [Canada] ; David G. Patry [Canada] ; Yahya Agha-Khani [Canada] ; Christopher White [Canada] ; Justyna R. Sarna [Canada] ; Michael Yeung [Canada] ; V Wee Yong [Canada] ; Daniel Y C. Heng [Canada] ; Gary Cutter [États-Unis] ; Luanne Metz [Canada] | The promise of futility trials in neurological diseases. |
| 000540 (2015) |
Satya Narayana Patro ; Rafael Glikstein ; Prasad Hanagandi ; Santanu Chakraborty | Role of neuroimaging in multidisciplinary approach towards Non-Alzheimer’s dementia |
| 000780 (2015) |
Shaun S. Sanders [Canada] ; Dale D. O. Martin [Canada] ; Stefanie L. Butland [Canada] ; Mathieu Lavallée-Adam [États-Unis] ; Diego Calzolari [États-Unis] ; Chris Kay [Canada] ; John R. Yates [États-Unis] ; Michael R. Hayden [Canada] | Curation of the Mammalian Palmitoylome Indicates a Pivotal Role for Palmitoylation in Diseases and Disorders of the Nervous System and Cancers |
| 000833 (2015) |
Carrie Esopenko ; Brian Levine | Aging, Neurodegenerative Disease, and Traumatic Brain Injury: The Role of Neuroimaging |
| 000939 (2014) |
Michael D. Fox ; Randy L. Buckner ; Hesheng Liu ; M. Mallar Chakravarty [Canada] ; Andres M. Lozano [Canada] ; Alvaro Pascual-Leone | Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases |
| 000972 (2014) |
Suk-Yu Yau [Canada] ; Joana Gil-Mohapel [Canada] ; Brian R. Christie [Canada] ; Kwok-Fai So [Hong Kong, République populaire de Chine] | Physical Exercise-Induced Adult Neurogenesis: A Good Strategy to Prevent Cognitive Decline in Neurodegenerative Diseases? |
| 000A19 (2014) |
Lindsey B. Gano ; Manisha Patel ; Jong M. Rho [Canada] | Ketogenic diets, mitochondria, and neurological diseases |
| 000C93 (2013) |
Khushwant S. Bhullar [Canada] ; H. P. Vasantha Rupasinghe [Canada] | Polyphenols: Multipotent Therapeutic Agents in Neurodegenerative Diseases |
| 000D12 (2013) |
Chunyan Guo ; Li Sun ; Xueping Chen ; Danshen Zhang | Oxidative stress, mitochondrial damage and neurodegenerative diseases |
| 000D81 (2013) |
Kristen Marciniuk [Canada] ; Ryan Taschuk [Canada] ; Scott Napper [Canada] | Evidence for Prion-Like Mechanisms in Several Neurodegenerative Diseases: Potential Implications for Immunotherapy |
| 000E09 (2013) |
Bo-Rim Yi [Corée du Sud] ; Seung U. Kim [Canada, Corée du Sud] ; Kyung-Chul Choi [Corée du Sud] | Development and application of neural stem cells for treating various human neurological diseases in animal models |
| 000F68 (2013) |
Seung U. Kim [Corée du Sud, Canada] ; Hong J. Lee [Corée du Sud, Canada] ; Yun B. Kim [Corée du Sud] | Neural stem cell‐based treatment for neurodegenerative diseases |
| 001040 (2013) |
Hong-Lei Li [République populaire de Chine] ; Shen-Ji Lu [République populaire de Chine] ; Yi-Min Sun [République populaire de Chine] ; Qi-Hao Guo [République populaire de Chine] ; Adele Dessa Sadovnick [Canada] ; Zhi-Ying Wu [République populaire de Chine] | The LRRK2 R1628P Variant Plays a Protective Role in Han Chinese Population with Alzheimer's Disease |
| 001247 (2012) |
Jean E. Vance [Canada] | Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases |
| 001528 (2012) |
Olena Babenko [Canada] ; Igor Kovalchuk [Canada] ; Gerlinde A. Metz [Canada] | Epigenetic programming of neurodegenerative diseases by an adverse environment |
| 001535 (2012) |
I. H. Mustafa [Canada] ; A. Elkamel [Canada] ; P. Chen [Canada] ; G. Ibrahim [Égypte] ; S. S. E. H. Elnashaie [États-Unis] | Effect of cholineacetyltransferase activity and choline recycle ratio on diffusion-reaction modeling, bifurcation and chaotic behavior of acetylcholine neurocycle and their relation to Alzheimer's and Parkinson's diseases |
| 001612 (2011) |
C. Gibrat ; F. Cicchetti | Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases. |
| 001923 (2011) |
C. Gibrat [Canada] ; F. Cicchetti [Canada] | Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases : THE NEUROBIOLOGY OF NEURODEGENERATIVE DISORDER: FROM BASIC TO CLINICAL RESEARCH |
| 001D31 (2010) |
Mélanie Bousquet [Canada] ; Claire Gibrat [Canada] ; Mélissa Ouellet [Canada] ; Claude Rouillard [Canada] ; Frédéric Calon [Canada] ; Francesca Cicchetti [Canada] | Cystamine metabolism and brain transport properties: clinical implications for neurodegenerative diseases |
| 001F53 (2009) |
Seung U. Kim [Canada, Corée du Sud] ; Jean De Vellis [États-Unis] | Stem cell‐based cell therapy in neurological diseases: A review |
| 002000 (2009) |
Jianjia Fan [Canada] ; James Donkin [Canada] ; Cheryl Wellington [Canada] | Greasing the wheels of Aβ clearance in Alzheimer's Disease: The role of lipids and apolipoprotein E |
| 002075 (2009) |
I. H. Mustafa [Canada] ; G. Ibrahim [Égypte] ; A. Elkamel [Canada] ; S. S. E. H. Elnashaie [États-Unis] ; P. Chen [Canada] | Non-linear feedback modeling and bifurcation of the acetylcholine neurocycle and its relation to Alzheimer's and Parkinson's diseases |
| 002102 (2009) |
I. H. Mustafa [Canada] ; A. Elkamel [Canada] ; G. Ibrahim [Égypte] ; P. Chen [Canada] ; S. S. E. H. Elnashaie [Égypte] | Effect of choline and acetate substrates on bifurcation and chaotic behavior of acetylcholine neurocycle and Alzheimer's and Parkinson's diseases |
| 002372 (2008) |
Michal Harciarek [Canada, Pologne] ; Andrew Kertesz [Canada] | The Prevalence of Misidentification Syndromes in Neurodegenerative Diseases |
| 002451 (2007) |
Sheng Chen ; Ian R. Brown | Neuronal expression of constitutive heat shock proteins: implications for neurodegenerative diseases |
| 002452 (2007) |
Christopher A. Shaw ; Günter U. Höglinger | Neurodegenerative Diseases: Neurotoxins as Sufficient Etiologic Agents? |
| 002495 (2007) |
P. T. T. Ly [Canada] ; S. Singh [Canada] ; C. A. Shaw [Canada] | Novel environmental toxins: Steryl glycosides as a potential etiological factor for age‐related neurodegenerative diseases |
| 002661 (2007) |
Frédéric Calon [Canada] ; Greg Cole [États-Unis] | Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases : Evidence from animal studies |
| 002827 (2006) |
Mle Macdonald [Canada] | Ironing out neurodegeneration: mutations in a phospholipase A2 cause neurodegenerative diseases with iron accumulation |
| 002921 (2006) |
Catherine L. Burton [Canada] ; Esther Strauss [Canada] ; David F. Hultsch [Canada] ; Alex Moll [Canada] ; Michael A. Hunter [Canada] | Intraindividual variability as a marker of neurological dysfunction : A comparison of Alzheimer's disease and Parkinson's disease |
| 002A66 (2005) |
K. Michno [Canada] ; D. Van De Hoef [Canada] ; H. Wu ; Gl Boulianne [Canada] | Demented flies? using Drosophila to model human neurodegenerative diseases |
| 002B14 (2005) |
Shawn Hayley [Canada] ; Hymie Anisman [Canada] | Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: Neurochemical and molecular substrates : The role of cytokines in neurodegeneration and psychiatric conditions: Multiple mechanisms of action |
| 002B35 (2005) |
Thomas E. Marler [États-Unis] ; Vivian Lee [Canada] ; Christopher A. Shaw [Canada] | Cycad toxins and neurological diseases in guam : Defining theoretical and experimental standards for correlating human disease with environmental toxins |
| 002B37 (2005) |
Katie Wiltshire [Canada] ; Sheri Foster [Canada] ; Jeffrey A. Kaye [États-Unis] ; Brent J. Small [États-Unis] ; Richard Camicioli [Canada] | Corpus callosum in neurodegenerative diseases : Findings in Parkinson's disease |
| 003060 (2002) |
Andrew J. Thompson [Royaume-Uni] ; Colin J. Barrow [Canada] | Protein conformational misfolding and amyloid formation: Characteristics of a new class of disorders that include Alzheimer's and Prion diseases |
| 003528 (2000) |
Claudia Schwab [Canada] ; Anthony J. Demaggio [États-Unis] ; Nupur Ghoshal [États-Unis] ; Lester I. Binder [États-Unis] ; Jeff Kuret [États-Unis] ; Patrick L. Mcgeer [Canada] | Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases |
| 003547 (2000) |
E. B. Mukaetova-Ladinska [États-Unis] ; J. Hurt [États-Unis] ; R. Jakes [États-Unis] ; J. Xuereb [États-Unis, Royaume-Uni] ; W. G. Honer [Canada] ; C. M. Wischik [Royaume-Uni] | α-Synuclein inclusions in Alzheimer and Lewy body diseases |
| 003615 (1999) |
H M Schipper [Canada] | Glial HO-1 expression, iron deposition and oxidative stress in neurodegenerative diseases. |
| 003A16 (1998) |
E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | The future use of complement inhibitors for the treatment of neurological diseases |
| 003A40 (1998) |
P. L. Mcgeer [Canada] ; E. G. Mcgeer [Canada] | Glial cell reactions in neurodegenerative diseases : Pathophysiology and therapeutic interventions |
| 003A63 (1997) |
E G Mcgeer [Canada] ; P L Mcgeer | The role of the immune system in neurodegenerative disorders. |
| 003E73 (1996) |
J. J. Claus [Pays-Bas] ; E. Mohr [Canada] | Attentional deficits in Alzheimer's, Parkinson's, and Huntington's diseases |
| 004098 (1995) |
P. Chagnon [Canada] ; C. Betard ; Y. Robitaille ; A. Cholette ; D. Gauvreau | Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases |
| 004301 (1994) |
O. Yasuhara [Canada] ; T. Kawamata ; Y. Aimi ; E. G. Mcgeer ; P. L. Mcgeer | Expression of chromogranin A in lesions in the central nervous system from patients with neurological diseases |
| 004425 (1993) |
Ananda Prasad Sen [Canada] ; Patricia Boksa [Canada] ; Rémi Quirion [Canada] | Brain calcium channel related dihydropyridine and phenylalkylamine binding sites in Alzheimer's, Parkinson's and Huntington's diseases |
| 004450 (1993) |
A. Beuter [Canada] ; J. Belair ; C. Labrie | Feedback and delays in neurological diseases: a modeling study using dynamical systems |
| 004461 (1993) |
A. P. Sen [Canada] ; P. Boksa ; R. Quirion | Brain calcium channel related dihydropyridine and phenylalkylamine binding sites in Alzheimer's, Parkinson's and Huntington's diseases |
| 004621 (1992) |
| 3 rd Canadian conference on neurodegenerative diseases, L'Estérel PQ, April 4-6, 1991 |
| 004656 (1992) |
I. Aubert [Canada] ; D. M. Araujo ; D. Cecyre ; Y. Robitaille ; S. Gauthier ; R. Quirion | Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases |
| 004A15 (1989) |
C. Bergeron [Canada] ; M. Pollanen | Lewy bodies in Alzheimer disease--one or two diseases? |
| 004B30 (1989) |
R. J. Uitti ; A. H. Rajput ; B. Rozdilsky ; M. Bickis ; T. Wollin ; W. K. Yuen | Regional metal concentrations in Parkinson1s disease, other chronic neurological diseases, and control brains |
| 004C77 (1987) |
P. Seeman [Canada] ; N H Bzowej ; H C Guan ; C. Bergeron ; G P Reynolds ; E D Bird ; P. Riederer ; K. Jellinger ; W W Tourtellotte | Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. |
| 004C82 (1987) |
H D Foster [Canada] | Disease family trees: the possible roles of iodine in goitre, cretinism, multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's and Parkinson's diseases and cancers of the thyroid, nervous system and skin. |
| 004D82 (1987) |
M. Freedman ; M. Oscar-Berman | Tactile discrimination learning deficits in Alzheimer's and Parkinson's diseases |
| 005589 (????) |
Michal Harciarek [Canada] ; Andrew Kertesz | The prevalence of misidentification syndromes in neurodegenerative diseases. |
| 005618 (????) |
Frédéric Calon [Canada] ; Greg Cole | Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. |
| 005655 (????) |
C. Schwab [Canada] ; A J Demaggio ; N. Ghoshal ; L I Binder ; J. Kuret ; P L Mcgeer | Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases. |
| 000003 (2017) |
Jerry M. Cuttler [Canada] ; Eugene R. Moore [États-Unis] ; Victor D. Hosfeld [États-Unis] ; David L. Nadolski [États-Unis] | Update on a Patient With Alzheimer Disease Treated With CT Scans |
| 000006 (2017) |
Stéphane Lehericy [France] ; David E. Vaillancourt [États-Unis] ; Klaus Seppi [Autriche] ; Oury Monchi [Canada] ; Irena Rektorova [République tchèque] ; Angelo Antonini [Italie] ; Martin J. Mckeown [Canada] ; Mario Masellis [Canada] ; Daniela Berg [Allemagne] ; James B. Rowe [Royaume-Uni] ; Simon J G. Lewis [Australie] ; Caroline H. Williams-Gray [Royaume-Uni] ; Alessandro Tessitore [Italie] ; Hartwig R. Siebner [Danemark] | The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward. |
| 000007 (2017) |
Stephen W. Pedersen [Danemark] ; Martin Suedmeyer [Allemagne] ; Louis W C. Liu [Canada] ; Dirk Domagk [Allemagne] ; Alison Forbes [États-Unis] ; Lars Bergmann [États-Unis] ; Koray Onuk [États-Unis] ; Ashley Yegin [États-Unis] ; Teus Van Laar [Pays-Bas] | The role and structure of the multidisciplinary team in the management of advanced Parkinson’s disease with a focus on the use of levodopa–carbidopa intestinal gel |
| 000011 (2017) |
Helen Tremlett [Canada] ; Kylynda C. Bauer [Canada] ; Silke Appel-Cresswell [Canada] ; Brett B. Finlay [Canada] ; Emmanuelle Waubant [États-Unis] | The gut microbiome in human neurological disease: A review. |
| 000015 (2017) |
Sali M K. Farhan [Canada] ; Robert Bartha [Canada] ; Sandra E. Black [Canada] ; Dale Corbett [Canada] ; Elizabeth Finger [Canada] ; Morris Freedman [Canada] ; Barry Greenberg [Canada] ; David A. Grimes [Canada] ; Robert A. Hegele [Canada] ; Chris Hudson [Canada] ; Peter W. Kleinstiver [Canada] ; Anthony E. Lang [Canada] ; Mario Masellis [Canada] ; William E. Mcilroy [Canada] ; Paula M. Mclaughlin [Canada] ; Manuel Montero-Odasso [Canada] ; David G. Munoz [Canada] ; Douglas P. Munoz [Canada] ; Stephen Strother [Canada] ; Richard H. Swartz [Canada] ; Sean Symons [Canada] ; Maria Carmela Tartaglia [Canada] ; Lorne Zinman [Canada] ; Michael J. Strong [Canada] | The Ontario Neurodegenerative Disease Research Initiative (ONDRI). |
| 000033 (2017) |
Lei Xing [Canada] ; Maddie J. Venables [Canada] ; Vance L. Trudeau [Canada] | Role of aromatase and radial glial cells in neurotoxin-induced dopamine neuron degeneration and regeneration. |
| 000148 (2016) |
Roongroj Bhidayasiri [Japon] ; Kamolwan Boonpang [Thaïlande] ; Onanong Jitkritsadakul [Thaïlande] ; Susan M. Calne [Canada] ; Tove Henriksen [Danemark] ; Sally Trump [Royaume-Uni] ; Suchapit Chaiwong [Thaïlande] ; Phenprapa Susang [Thaïlande] ; Nonglak Boonrod [Thaïlande] ; Jirada Sringean [Thaïlande] ; Teus Van Laar [Pays-Bas] ; Martje Drent [Pays-Bas] ; K Ray Chaudhuri [Royaume-Uni] | Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therpy. |
| 000154 (2016) |
Jerry M. Cuttler [Canada] ; Eugene R. Moore [États-Unis] ; Victor D. Hosfeld [États-Unis] ; David L. Nadolski [États-Unis] | Treatment of Alzheimer Disease With CT Scans |
| 000161 (2016) |
Ziv Gan-Or [Canada] ; Noreen Mohsin [Canada] ; Simon L. Girard [Canada] ; Jacques Y. Montplaisir [Canada] ; Amirthagowri Ambalavanan [Canada] ; Stephanie Strong [Canada] ; Victoria Mallett [Canada] ; Sandra B. Laurent [Canada] ; Cynthia V. Bourassa [Canada] ; Michel Boivin [Russie] ; Melanie Langlois [Canada] ; Isabelle Arnulf [France] ; Birgit Högl [Autriche] ; Birgit Frauscher [Autriche] ; Christelle Monaca [France] ; Alex Desautels [Canada] ; Jean-François Gagnon [Canada] ; Ronald B. Postuma [Canada] ; Patrick A. Dion [Canada] ; Yves Dauvilliers [France] ; Nicolas Dupre [Canada] ; Roy N. Alcalay [États-Unis] ; Guy A. Rouleau [Canada] | The role of the melanoma gene MC1R in Parkinson disease and REM sleep behavior disorder. |
| 000162 (2016) |
Katja Lohmann [Allemagne] ; Felix Schlicht [Allemagne] ; Marina Svetel [Serbie] ; Frauke Hinrichs [Allemagne] ; Simone Zittel [Allemagne] ; Julia Graf [Allemagne] ; Thora Lohnau [Allemagne] ; Alexander Schmidt [Allemagne] ; Pablo Mir [Espagne] ; Patricia Krause [Allemagne] ; Antony E. Lang [Canada] ; Hans-Christian Jabusch [Allemagne] ; Alexander Wolters [Allemagne] ; Christoph Kamm [Allemagne] ; Kirsten E. Zeuner [Allemagne] ; Eckart Altenmüller [Allemagne] ; Sadaf Naz [Pakistan] ; Sun Ju Chung [Corée du Sud] ; Vladimir S. Kostic [Serbie] ; Alexander Münchau [Allemagne] ; Andrea A. Kühn [Allemagne] ; Norbert Brüggemann [Allemagne] ; Christine Klein [Allemagne] | The role of mutations in COL6A3 in isolated dystonia. |
| 000163 (2016) |
Musleh A. Algarni [Canada] ; A Jon Stoessl [Canada] | The role of biomarkers and imaging in Parkinson's disease. |
| 000171 (2016) |
Lu An [Canada] ; Paul M. Harrison [Canada] | The evolutionary scope and neurological disease linkage of yeast-prion-like proteins in humans |
| 000174 (2016) |
Gary Sweeney [Canada] ; Juhyun Song [Corée du Sud] | The association between PGC-1α and Alzheimer's disease |
| 000202 (2016) |
Anatol G. Feldman [Canada] ; Mindy F. Levin [Canada] | Spatial control of reflexes, posture and movement in normal conditions and after neurological lesions |
| 000207 (2016) |
Kaviraja Udupa [Canada] ; Robert Chen [Canada] | Role of dopamine in motor cortex plasticity in Parkinson's disease. |
| 000208 (2016) |
Mohammed Emehdi Atef ; Madhu B. Anand-Srivastava | Role of PKCδ in Enhanced Expression of Gqα/PLCβ1 Proteins and VSMC Hypertrophy in Spontaneously Hypertensive Rats |
| 000219 (2016) |
Philippe Desmarais [Canada] ; Fadi Massoud [Canada] ; Josée Filion [Canada] ; Quoc Dinh Nguyen [Canada] ; Paulina Bajsarowicz [Canada] | Quetiapine for Psychosis in Parkinson Disease and Neurodegenerative Parkinsonian Disorders: A Systematic Review. |
| 000236 (2016) |
Jinhui Ma [Canada] ; Lehana Thabane [Canada] ; Joseph Beyene [Canada] ; Parminder Raina [Canada] | Power Analysis for Population-Based Longitudinal Studies Investigating Gene-Environment Interactions in Chronic Diseases: A Simulation Study |
| 000336 (2016) |
Luis E. B. Bettio ; Joana Gil-Mohapel ; Ana Lúcia S. Rodrigues | Guanosine and its role in neuropathologies |
| 000366 (2016) |
Andrea M A. Schreij [Canada] ; Edward A. Fon [Canada] ; Peter S. Mcpherson [Canada] | Endocytic membrane trafficking and neurodegenerative disease. |
| 000391 (2016) |
Philippe Finès [Canada] ; Rochelle Garner [Canada] ; Christina Bancej [Canada] ; Julie Bernier [Canada] ; Douglas G. Manuel | Development and implementation of microsimulation models of neurological conditions. |
| 000405 (2016) |
Stephanie Yamin [Canada] ; Arne Stinchcombe [Canada] ; Sylvain Gagnon [Canada] | Comparing Cognitive Profiles of Licensed Drivers with Mild Alzheimer's Disease and Mild Dementia with Lewy Bodies |
| 000430 (2016) |
Francisco A. Ponce ; Wael F. Asaad ; Kelly D. Foote ; William S. Anderson ; G. Rees Cosgrove ; Gordon H. Baltuch [États-Unis] ; Kara Beasley [États-Unis] ; Donald E. Reymers ; Esther S. Oh ; Steven D. Targum ; Gwenn S. Smith [États-Unis] ; Constantine G. Lyketsos [États-Unis] ; Andres M. Lozano [Canada] | Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the ADvance trial. |
| 000475 (2015) |
E. Baratin [France] ; L. Sugavaneswaran [Canada] ; K. Umapathy [Canada] ; C. Ioana [France] ; S. Krishnan [Canada] | Wavelet-based characterization of gait signal for neurological abnormalities. |
| 000478 (2015) |
Sejal Patel [Canada, Royaume-Uni] ; Paola Roncaglia ; Ruth C. Lovering [Royaume-Uni] | Using Gene Ontology to describe the role of the neurexin-neuroligin-SHANK complex in human, mouse and rat and its relevance to autism |
| 000490 (2015) |
João P. Lopes [Portugal] ; Xavier Morat [Espagne] ; Carolina Souza [Portugal] ; Cindy Pinhal [Portugal] ; Nuno J. Machado [Portugal] ; Paula M. Canas [Portugal] ; Henrique B. Silva [Portugal] ; Igor Stagljar [Canada] ; Jorge Gandía [Espagne] ; Víctor Fernández-Due As [Espagne] ; Rafael Luján [Espagne] ; Rodrigo A. Cunha [Portugal] ; Francisco Ciruela [Espagne] | The role of parkinson's disease-associated receptor GPR37 in the hippocampus: functional interplay with the adenosinergic system. |
